Induction of Urokinase-type Plasminogen Activator Receptor by IL-Iβ

American Journal of Respiratory Cell and Molecular Biology

Volumn 16, Issue 6, 1997, Pages 683-692

  Hasegawa, Takashi ^b   Sorensen, Lise ^b   Dohi, Makoto ^b   Rao, Narayanam V ^b   Hoidal, John R ^b   Marshall, Bruce C ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RICKETTSIA SP. PAR;

AUTACOID; CELL SURFACE RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MESSENGER RNA; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS; PROTEIN KINASE C; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; NORTHERN BLOTTING; SIGNAL TRANSDUCTION; UPREGULATION;

BLOTTING, NORTHERN; CELLS, CULTURED; EPITHELIAL CELLS; EPITHELIUM; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; LUNG; NF-KAPPA B; PLASMIN; PLASMINOGEN ACTIVATORS; PROTEIN KINASE C; RECEPTORS, CELL SURFACE; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0031159964     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.16.6.9191470     Document Type: Article

References (45)

1. Marshall, B. C., Q.-P. Xu, N. V. Rao, B. R. Brown, and J. R. Hoidal. 1992. Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1 beta and tumor necrosis factor-alpha. J. Biol. Chem. 267:11462-11469.
2. Vassalli, J.-D., A.-P. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067-1072.
3. Roldan, A. L., M. V. Cubellis, M. T. Masucci, N. Behrendt, L. R. Lund, K. Dano, E. Appella, and F. Blasi. 1990. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proleolysis. EMBO J. 9:467-474.
4. Ploug, M., E. Ronne, N. Behrendt, A. L. Jensen, F. Blasi, and K. Dano, 1991. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem. 266:1926-1933.
5. Plow, E. F., D. E. Freaney, J. Plescia, and L. A. Miles. 1986. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J. Cell Biol. 103:2411-2420.
6. Gyetko, M. R., R. F. Todd, III, C. C. Wilkinson, and R. G. Sitrin. 1994. The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest. 93:1380-1387.
7. Busso, N., S. K. Masur, D. Laxega, S. Waxman, and L. Ossowski. 1994. Induction of cell migration by pro-urokinase binding to its receptor: possible-mechanism for signal transduction in human epithelial cells. J. Cell Biol. 126:259-270.
8. Waltz, D. A., and H. A. Chapman. Jr. 1994. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269: 14746-14750.
9. Pratt, P. C., R. T. Vollmer, J. D. Shelburne, and J. D. Crapo. 1979. Pulmonary morphology in a multihospilal collaborative extracorporeal membrane oxygenation project. Am. J. Pathol. 95:191-214.
10. Elliott, C. G., A. H. Morris, and M. Cengiz. 1981. Pulmonary function and exercise gas exchange in survivors of adult respiratory distress syndrome. Am. Rev. Respir. Dis. 123:492-495.
11. Well, S., J. Peters, K. K. James, D. S. Fair, and J. J. Coalson. 1989. Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage. J. Clin. Invest. 84:181-193.
12. Bertozzi, P., B. Astedt, L. Zenzius, K. Lynch, F. LeMaire, W. Zapol, and H. A. Chapman, Jr. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N. Engl. J. Med. 322:890-897.
13. Marshall, B. C., D. S. Sageser, N. V. Rao, M. Emi, and J. R. Hoidal. 1990. Alveolar epithelial cell plasminogen activator, characterization and regulation. J. Biol. Chem. 265:8198-8204.
14. Gross, T. J., R. H. Simon, C. J. Kelly, and R. G. Sitrin. 1991. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am. J. Physiol. 260:L286-L295.
15. Gross, T. J., R. H. Simon, and R. G. Sitrin. 1990. Expression of urokinase-type plasminogen activator by rat pulmonary alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 3:449-456.
16. Simon, R. H., T. J. Gross, J. A. Edwards, and R. G. Sitrin. 1992. Fibrin degradation by rat pulmonary alveolar epithelial cells. Am. J. Physiol. 262: L482-L4H8.
17. Stephens, R. W., J. Pollanen, H. Topiovaara, K.-C. Leung, P.-S. Sim, E.-M. Salonen, E. Ronne, N. Behrendt, K. Dano, and A. Vaheri. 1989. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J. Cell Biol. 108: 1987-1995.
18. Dignam, J. D., R. M. Lebovitz and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
19. Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741-752.
20. Lund, L. R., J. Romer, E. Ronne, V. Ellis, F. Blasi, and K. Dano. 1991. Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells. EMBO J. 10:3399-3407.
21. Lund, L. R., E. Ronne, A. L. Roldan, N. Behrendt, J. Romer, F. Blasi, and K. Dano. 1991. Urokinase-receptor mRNA level and gene transcription are strongly and rapidly increased by PMA in human monocyte-like U937 cells. J. Biol Chem. 266:5177-5181.
22. Schuetz, J. D., S. C. Strom, and E. G. Schuetz. 1995. Induction of P-glycoprotein mRNA by protein synthesis inhibition is not controlled by a transcriptional repressor protein in rat and human liver cells. J. Cell. Physiol. 165:261-272.
23. Bruns, R. F., F. D. Miller, R. L. Merriman, J. J. Howbert, W. F. Heath, E. Kobayashi, I. Takahashi, T. Tamaoki, and H. Nakano. 1991. Inhibition of protein kinase C by calphostin C is light-dependent. Biochem. Biophys. Res. Commun. 176:288-293.
24. Peppel, K., J. M. Vinci, and C. Baglioni. 1991. The AU-rich sequences in the 3' untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J. Exp. Med. 173:349-355.
25. Heck, S., M. Kallman, A. Gast, H. Ponta, H. J. Rahmsdorf, P. Herrlich, and A. C. B. Cato. 1994. A distinct modulating domain in glucocorticoid monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13:4087-4095.
26. Helmberg, A., N. Auphan, C. Caelles, and M. Karin. (1995). Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 14:452-4611.
27. Chen, J. Y., S. Penco, J. Ostrowski, P. Balaguer, M. Pons, J. E. Starrett, P. Reczek, P. Chambon, and H. Gronemeyer. 1995. RAR-specific agonist/antagonists which dissociate transactivation and AP-1 transrepression inhibit anchorage independent cell proliferation. EMBO J. 14:1187-1197.
28. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91:752-756.
29. Soravia, E., A. Grebe, P. DeLuca, K. Helin, T. T. Suh, J. L. Degen, and F. Blasi. 1995. A conserved TATA-less proximal promoter drives basal transcription from the urokinase type plasminogen activator receptor gene. Blood 86:624-635.
30. Ray, K. P., and N. Kennard. 1993. Interleukin-1 induces a nuclear form of transcription factor NF-κB in human lung epithelial cells. Agents Aations 38:C61-C63.
31. Keski-Oja, J., F. Blasi, E. B. Leof, and H. L. Moses. 1988. Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta. J. Cell Biol. 106: 451-459.
32. Guy, G. R., S. P. Chua, N. S. Wong, S. B. Ng, and Y. H. Tan. 1991. Interleukin I and tumor necrosis factor activate common multiple protein kinases in human fibroblasls. J. Biol. Chem. 266:14343-14352.
33. O'Neill, L. A. 1995. Towards an understanding of the signal transduction pathways for interleukin-1. Biochim. Biophys. Acta 1266:31-44.
34. Guy, G. R., X. Cao, S. P. Chua, and Y. H. Tan. 1992. Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J. Biol. Chem. 267:1846-1852.
35. Lund, L. R., and K. Dano. 1992. Okadaic acid strongly increases gene transcription, mRNA and protein level for the urokinase receptor in human A549 cells. FEBS Lett. 298:177-181.
36. Langer, D. J., A. Kuo, K. Kariko, M. Ahuja, B. D. Klugherz, K. M. Ivanics, J. A. Hoxie, W. V. Williams, B. T. Liang, D. B. Cines, and E. S. Barnathan. 1993. Regulation of the endothelial cell urokinase-type plasminogen activator receptor: evidence for cyclic AMP-dependent and protein kinase C-dependent pathways. Circ. Res. 72:330-340.
37. Bernard, G. R., J. M. Luce, C. L. Sprung, J. E. Rinaldo, R. M. Tate, W. J. Sibbald, K. Kariman, S. Higgins, R. Bradley, C. A. Metz, T. R. Harris, and K. L. Brigham. 1987. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N. Engl. J. Med. 317:1565-1570.
38. Smith, L. J., and J. S. Brody. 1981. Influence of methylprednisolone on mouse alveolar type 2 cell response to acute lung injury. Am. Res. Respir. Dis. 123:459-464.
39. Kehrer, J. P., A. J. Klein-Szanto, E. M. Sorensen, R. Pearlman, and M. H. Rosner. 1984. Enhanced acute lung damage following corticostcroid treatment. Am. Rev. Respir. Dis. 130:256-261.
40. Illek, B., H. Fischer, and W. Clauss. 1990. Aldosterone regulation of basolateral potassium channels in alveolar epithelium. Am. J. Physiol. 259:L230-L237.
41. Zach, T. L., V. A. Herrman, L. D. Hill, and M. P. Leuschen. 1993. Effect of steroids on the synthesis of complement C3 in a human alveolar epithelial cell line. Exp. Lung Res. 19:603-616.
42. Muegge, K., M. Vila, O. L. Gusella, T. Musso, P. Herrlich, B. Stein, and S. K. Durum. 1993. Interleukin-1 induction of the c-jun promoter. Proc. Natl. Acad. Sci. USA 90:7054-7058.
43. Lee, W. Y., A. P. Butler, M. F. Locniskar, and S. M. Fischer. 1994. Signal transduction pathway(s) involved in phorbol ester and autocrine induction of interleukin-1 alpha mRNA in murine keratinocytes. J. Biol. Chem. 269: 17971-17980.
44. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-κB activation. Mol. Cell Biol. 13: 3301-3310.
45. Stylianou, E., L. A. O'Neill, L. Rawlinson, M. R. Edbrooke, P. Woo, and J. Saklatvala. 1992. Interleukin 1 induces NF-κB through its type 1 but not its type II receptor in lymphocytes. J. Biol. Chem. 267:15836-15841.